|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
1561
|
Fallypride tartrate salt
|
1561.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Reference standard for [18F]Fallypride
|
|
|
|
|
|
|
|
|
Molar Mass: 514.54
|
|
|
C20H29FN2O3 ⋅ C4H6O6
|
|
|
CAS-RN not yet assigned
|
|
|
Fallypride free base: [166173-78-0]
|
|
|
Colourless solid packaged in dark glass screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H and 19F NMR spectra
|
|
|
Chemical Name:
Benzamide, 5-(3-fluoropropyl)-2,3-dimethoxy-N-[[(2S)-1-(2-propenyl)-2-pyrrolidinyl]methyl]-, tartrate salt
|
|
|
Synonymes:
(S)-5-(3-fluoropropyl)-2,3-dimethoxy-N-[[(2S)-1-(2-propenyl)-2-pyrrolidinyl]methyl]-; tartrate salt
|
|
|
Literature:
1. Mukherjee J. et al. Preliminary Assessment of Extrastriatal Dopamine D-2 Receptor Binding in the Rodent and Nonhuman Primat Brains Using the High Affinity Radioligand, [18F]-Fallypride. Nucl. Med. Biol. 1999, 26, 519-527.
|
|
|
2. Mukherjee J. et al. Fluorinated Benzamide Neuroleptics - III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-[3-[18F]fluoro-propyl)dimethoxybenzamide as an Improved Dopamine D-2 Receptor Tracer. Nucl. Med. Biol. 1995, 22, 283-296.
|
|
|
3. Mukherjee J. et al. Evaluation of d-Amphetamine Effects on the Binding of Dopamine D-2 Receptor Radioligand, [18F]-Fallypride in Nonhuman Primates Using Positron Emission Tomography. Synapse 1997, 27, 1-13.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|